2014-05-07
Neutralizing the MERS coronavirus threat
Publication
Publication
Science Translational Medicine , Volume 6 - Issue 235
Human neutralizing monoclonal antibodies are candidates for prophylactic and therapeutic interventions against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
| Additional Metadata | |
|---|---|
| doi.org/10.1126/scitranslmed.3009132, hdl.handle.net/1765/55033 | |
| Science Translational Medicine | |
| Organisation | Department of Virology |
|
Haagmans, B., & Osterhaus, A. (2014). Neutralizing the MERS coronavirus threat. Science Translational Medicine, 6(235). doi:10.1126/scitranslmed.3009132 |
|